Clinical trial
PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate…
NCT01314313 · Edwards Lifesciences, Industry · Completed
Key facts
| NCT number | NCT01314313 |
|---|---|
| Title | PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk |
| Official title | Edwards SAPIEN XT Transcatheter Heart Valve Therapy for Intermediate and High Risk Patients |
| Acronym | PII A |
| Lead sponsor | Edwards Lifesciences, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Symptomatic Severe Aortic Stenosis |
| Intervention type | Device |
| Interventions | TAVR Implantation with SAPIEN XT, SAVR Implantation |
| Enrollment | 2,032 |
| Start date | Mar 1, 2011 |
| Primary completion | Jan 1, 2016 |
| Completion | Jan 17, 2024 |
| First posted | Mar 14, 2011 |
| Last update posted | Mar 7, 2024 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: